Background Image
Table of Contents Table of Contents
Previous Page  107 / 658 Next Page
Information
Show Menu
Previous Page 107 / 658 Next Page
Page Background

5

Thermo Scientific Poster Note

PN-64078-ASMS-EN-0614S

Conclusions

Automated sample extr

thus decreasing sampl

Insulin MSIA D.A.R.T.’

present at different con

quantification for resea

HRAM MS affords qual

variants present in one

Pinpoint software versi

confirmation, and quan

Reduced complexity aff

LC/MS analysis times.

An LLOD < 15 pM and

were achieved.

Intra- and inter-day rep

MSIA workflow highly r

References

1. Thevis, M, Thomas, A.,

27(1)

, 35-50.

Acknowledgem

The authors would like to than

UK for the donation of the ins

ogs

ntification of insulin and its

n protocols that result in their lack

ulin MSIA workflow described

pg/mL) for the intact variants in

are shown in Figure 4. Tables 1

nd intra-day CVs of < 3%

ecoveries of 96

100% (Table 5).

flow significantly reduces the

shorter LC gradients, and,

For Research Use Only. Not

Humulin is a registered trademark of Eli Lil

trademarks are the property of Thermo Fis

This information is not intended to encoura

intellectual property rights of others.

pidra. Lantus and Apidra were

ons. The endogenous insulin

same amount of donor plasma

us insulin remains static. All

response.

TABLE 1. Limit of quantification

STD Conc.

(pM)

Mean

(5 Curves)

StDev

%CV

Accuracy

0

7.42

1.02

7.5

10.56

0.95

9.04%

40.80%

15

16.78

1.42

8.46%

11.87%

30

28.96

1.12

3.85%

-3.46%

60

58.41

1.61

2.75%

-2.66%

120

115.93

1.96

1.69%

-3.39%

240

232.65

2.80

1.20%

-3.06%

480

473.25

14.41

3.04%

-1.41%

960

963.31

6.47

0.67%

0.34%

TABLE 2. Limit of detection

STD Conc.

(pM)

Mean Total File

Area

4

StDev

Plus 4

StDev

0

2.37E+05

2.20E+05

4.57E+05

7.5

2.80E+05

15

4.79E+05

30

8.93E+05

TABLE 5. Spike and recovery

Sample

Spike Conc.

(pM)

Neat_1

0.00

Neat_2

Neat_3

Low_1

19.50

Low_2

Low_3

Medium_1

199.50

Medium_2

Medium_3

High_1

919.50

High_2

High_3

TABLE 3. Intra-day repeatability

STD Conc.

(pM)

Mean

(3 Controls x

5 Curves)

StDevp

%CV

Accuracy

50.00

51.21

1.33

3

2.43%

TABLE 4. Inter-day repeatability

STD Conc.

(pM)

Mean

(3 Controls x

5 Curves)

StDevp

%CV

Accuracy

50.00

51.07

0.81

2

2.15%

Method Characteristics for the MSIA Insulin Research Workflow

The LLOQ for the insulin MSIA research workflow is 15 pM (highlighted in red in

Table 1), which was determined as the lowest concentration where we could achieve a

%CV of <20% and an accuracy within ±20%.

An LOD of 15 pM (highlighted in red in Table 2) was also achieved for the insulin MSIA

workflow. The LLOD was determined as the lowest concentration where the mean total

area was greater than four standard deviations of the background signal added to the

mean total area for the blank.

insulin variants. Apidra

) ,

and porcine as the internal

and detected simultaneously.

state, and shows all three

ree displayed insulin variants.

1600 1700 1800 1900 2000

60 1162 1164 1166 1168 1170 1172 1174

m/z

Apidra

Humulin® S

Apidra

TM

+ Na

+

Apidra

TM

+ K

+

2x + 0.1087

0.996

y = 0.0103x + 0.463

R²= 0.9883

400

500

er Sample (pM)